CN112386554A - 一种祛痘、去痘印、去闭合性粉刺的面霜 - Google Patents
一种祛痘、去痘印、去闭合性粉刺的面霜 Download PDFInfo
- Publication number
- CN112386554A CN112386554A CN201910767307.7A CN201910767307A CN112386554A CN 112386554 A CN112386554 A CN 112386554A CN 201910767307 A CN201910767307 A CN 201910767307A CN 112386554 A CN112386554 A CN 112386554A
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- cream
- closed
- acnes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 77
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 71
- 239000006071 cream Substances 0.000 title claims abstract description 33
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 32
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 21
- 241001116389 Aloe Species 0.000 claims abstract description 20
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 16
- 229960000458 allantoin Drugs 0.000 claims abstract description 16
- 235000014653 Carica parviflora Nutrition 0.000 claims abstract description 13
- 244000132059 Carica parviflora Species 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 229940111630 tea tree oil Drugs 0.000 claims abstract description 13
- 239000010677 tea tree oil Substances 0.000 claims abstract description 13
- 239000002562 thickening agent Substances 0.000 claims abstract description 13
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 13
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 13
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims abstract description 10
- 229940067599 ascorbyl glucoside Drugs 0.000 claims abstract description 10
- 229940105902 mint extract Drugs 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000013538 functional additive Substances 0.000 claims abstract description 6
- 208000020154 Acnes Diseases 0.000 claims abstract 10
- 239000007788 liquid Substances 0.000 claims description 9
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- -1 ascorbyl glycoside Chemical class 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- WOFTVESNUIDLHD-UHFFFAOYSA-N (2,4-dioxoimidazolidin-1-yl)urea Chemical compound NC(=O)NN1CC(=O)NC1=O WOFTVESNUIDLHD-UHFFFAOYSA-N 0.000 claims description 3
- PRZFUMHWRKSAGP-UHFFFAOYSA-N (3-oxoaziridin-2-yl)urea Chemical compound N(C(=O)N)C1C(=O)N1 PRZFUMHWRKSAGP-UHFFFAOYSA-N 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000011782 Keratins Human genes 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims description 3
- 241000234280 Liliaceae Species 0.000 claims description 3
- 206010072170 Skin wound Diseases 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000003699 antiulcer agent Substances 0.000 claims description 3
- 239000012752 auxiliary agent Substances 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 239000013003 healing agent Substances 0.000 claims description 3
- 150000001469 hydantoins Chemical class 0.000 claims description 3
- 235000020737 peppermint extract Nutrition 0.000 claims description 3
- 230000035790 physiological processes and functions Effects 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000029663 wound healing Effects 0.000 claims description 3
- 244000144927 Aloe barbadensis Species 0.000 claims 1
- 235000002961 Aloe barbadensis Nutrition 0.000 claims 1
- 230000001815 facial effect Effects 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000003467 diminishing effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 238000005562 fading Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000003997 social interaction Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下重量份的原料：抗坏血酸糖苷10‑20份、芦荟凝胶5‑7份、珊瑚提取液4‑6份、珍珠粉1‑2份、增稠剂3‑5份、功能助剂5‑7份、薄荷提取液8‑10份、茶树油4‑6份、尿囊素2‑4份和凝血酸3‑6份；本发明的有益效果是对有痘痘的肌肤进行维护，祛痘，淡化痘印、抗菌消炎、护肤，且使用方便，效果显著，见效快，无明显不良反应，安全无毒副作用。
Description
技术领域
本发明涉及化妆品的领域，尤其是涉及一种祛痘、去痘印、去闭合性粉刺的面霜。
背景技术
痤疮是毛囊皮脂腺单位的一种慢性炎症性皮肤病，主要好发于青少年，对青少年的心理和社交影响很大，但青春期后往往能自然减轻或痊愈。临床表现以好发于面部的粉刺、丘疹、脓疱、结节等多形性皮损为特点。痤疮的发生主要与皮脂分泌过多、毛囊皮脂腺导管堵塞、细菌感染和炎症反应等因素密切相关。进入青春期后人体内雄激素特别是睾酮的水平迅速升高，促进皮脂腺发育并产生大量皮脂。同时毛囊皮脂腺导管的角化异常造成导管堵塞，皮脂排出障碍，形成角质栓即微粉刺。毛囊中多种微生物尤其是痤疮丙酸杆菌大量繁殖，痤疮丙酸杆菌产生的脂酶分解皮脂生成游离脂肪酸，同时趋化炎症细胞和介质，最终诱导并加重炎症反。
现有技术中的痤疮治疗的常用方法主要有局部外用药物，如维A酸类(维A酸乳膏、阿达帕林凝胶、他扎罗汀凝胶)、过氧化苯甲酰、抗生素类(克林霉素、红霉素、氯霉素等)、壬二酸、硫磺洗剂等，祛痘、去痘印、去闭合性粉刺的功效不能持续，功效较慢，因此，开发一种祛痘、去痘印、去闭合性粉刺的面霜是目前亟待解决的问题。
发明内容
本发明为克服上述情况不足，旨在提供一种能解决上述问题的技术方案。
一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下重量份的原料：抗坏血酸糖苷10-20份、芦荟凝胶5-7份、珊瑚提取液4-6份、珍珠粉1-2份、增稠剂3-5份、功能助剂5-7份、薄荷提取液8-10份、茶树油4-6份、尿囊素2-4份和凝血酸3-6份。
一种祛痘、去痘印、去闭合性粉刺的面霜的制备方法，用于制备所述的一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下步骤：
S1、制备面霜基层液：将等量成分的芦荟凝胶、珊瑚提取液、珍珠粉、薄荷提取液和茶树油分别倒入化学混合锅中，并均匀搅拌混合；
S2、加入辅助剂：往S1中形成的面霜基层液逐渐加入等量成分的抗坏血酸糖苷、增稠剂、功能助剂、尿囊素和凝血酸，形成该产品。
作为本发明进一步的方案：所述芦荟凝胶是从多年生百合科芦荟叶的肉汁部分所得的液汁(经提纯加工)，主要有芦荟大黄素，芦荟蒽酮，多种糖类、酶、氨基酸等组成；为淡黄绿色液体，相对密度为0.98～1.02，pH值4～6。
作为本发明进一步的方案：所述尿囊素，别名5-尿基乙内酰胺、脲基醋酸内酰胺、脲基海因、脲咪唑二酮，是一种乙内酰脲衍生物；具有促进细胞生长，加快伤口愈合，软化角质蛋白等生理功能，是皮肤创伤的良好愈合剂和抗溃疡药剂。
作为本发明进一步的方案：所述S1中化学混合锅使用前需进行清洁消毒。
作为本发明进一步的方案：所述S1和S2中均匀需要玻璃棒进行混合搅拌。
与现有技术相比，本发明的有益效果是：对有痘痘的肌肤进行维护，祛痘，淡化痘印、抗菌消炎、护肤，且使用方便，效果显著，见效快，无明显不良反应，安全无毒副作用。
本发明的附加方面和优点将在下面的描述中部分给出，部分将从下面的描述中变得明显，或通过本发明的实践了解到。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例一
一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下重量份的原料：抗坏血酸糖苷10-20份、芦荟凝胶5-7份、珊瑚提取液4-6份、珍珠粉1-2份、增稠剂3-5份、功能助剂5-7份、薄荷提取液8-10份、茶树油4-6份、尿囊素2-4份和凝血酸3-6份。
一种祛痘、去痘印、去闭合性粉刺的面霜的制备方法，用于制备所述的一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下步骤：
S1、制备面霜基层液：将等量成分的芦荟凝胶、珊瑚提取液、珍珠粉、薄荷提取液和茶树油分别倒入化学混合锅中，并均匀搅拌混合；
S2、加入辅助剂：往S1中形成的面霜基层液逐渐加入等量成分的抗坏血酸糖苷、增稠剂、功能助剂、尿囊素和凝血酸，形成该产品。
实施例二
一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下重量份的原料：抗坏血酸糖苷10份、芦荟凝胶5份、珊瑚提取液4份、珍珠粉1份、增稠剂3份、功能助剂5份、薄荷提取液8份、茶树油4份、尿囊素2份和凝血酸3份。
其制备方法同实施例一一致。
实施例三
一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下重量份的原料：抗坏血酸糖苷15份、芦荟凝胶6份、珊瑚提取液5份、珍珠粉1.5份、增稠剂4份、功能助剂6份、薄荷提取液9份、茶树油5份、尿囊素3份和凝血酸5份。
其制备方法同实施例一一致。
实施例四
一种祛痘、去痘印、去闭合性粉刺的面霜，包括以下重量份的原料：抗坏血酸糖苷20份、芦荟凝胶7份、珊瑚提取液6份、珍珠粉2份、增稠剂5份、功能助剂7份、薄荷提取液10份、茶树油6份、尿囊素4份和凝血酸6份。
其制备方法同实施例一一致。
所述芦荟凝胶是从多年生百合科芦荟叶的肉汁部分所得的液汁(经提纯加工)，主要有芦荟大黄素，芦荟蒽酮，多种糖类、酶、氨基酸等组成；为淡黄绿色液体，相对密度为0.98～1.02，pH值4～6。
所述尿囊素，别名5-尿基乙内酰胺、脲基醋酸内酰胺、脲基海因、脲咪唑二酮，是一种乙内酰脲衍生物；具有促进细胞生长，加快伤口愈合，软化角质蛋白等生理功能，是皮肤创伤的良好愈合剂和抗溃疡药剂。
所述S1中化学混合锅使用前需进行清洁消毒。
所述S1和S2中均匀需要玻璃棒进行混合搅拌。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
Claims (9)
1.一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，包括以下重量份的原料：抗坏血酸糖苷10-20份、芦荟凝胶5-7份、珊瑚提取液4-6份、珍珠粉1-2份、增稠剂3-5份、功能助剂5-7份、薄荷提取液8-10份、茶树油4-6份、尿囊素2-4份和凝血酸3-6份。
2.根据权利要求1所述的一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，包括以下重量份的原料：抗坏血酸糖苷10份、芦荟凝胶5份、珊瑚提取液4份、珍珠粉1份、增稠剂3份、功能助剂5份、薄荷提取液8份、茶树油4份、尿囊素2份和凝血酸3份。
3.根据权利要求1所述的一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，包括以下重量份的原料：抗坏血酸糖苷15份、芦荟凝胶6份、珊瑚提取液5份、珍珠粉1.5份、增稠剂4份、功能助剂6份、薄荷提取液9份、茶树油5份、尿囊素3份和凝血酸5份。
4.根据权利要求1所述的一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，包括以下重量份的原料：抗坏血酸糖苷20份、芦荟凝胶7份、珊瑚提取液6份、珍珠粉2份、增稠剂5份、功能助剂7份、薄荷提取液10份、茶树油6份、尿囊素4份和凝血酸6份。
5.根据权利要求1所述的一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，所述芦荟凝胶是从多年生百合科芦荟叶的肉汁部分所得的液汁(经提纯加工)，主要有芦荟大黄素，芦荟蒽酮，多种糖类、酶、氨基酸等组成；为淡黄绿色液体，相对密度为0.98～1.02，pH值4～6。
6.根据权利要求1所述的一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，所述尿囊素，别名5-尿基乙内酰胺、脲基醋酸内酰胺、脲基海因、脲咪唑二酮，是一种乙内酰脲衍生物；具有促进细胞生长，加快伤口愈合，软化角质蛋白等生理功能，是皮肤创伤的良好愈合剂和抗溃疡药剂。
7.一种祛痘、去痘印、去闭合性粉刺的面霜的制备方法，用于制备权利要求1到6任一项所述的一种祛痘、去痘印、去闭合性粉刺的面霜，其特征在于，包括以下步骤：
S1、制备面霜基层液：将等量成分的芦荟凝胶、珊瑚提取液、珍珠粉、薄荷提取液和茶树油分别倒入化学混合锅中，并均匀搅拌混合；
S2、加入辅助剂：往S1中形成的面霜基层液逐渐加入等量成分的抗坏血酸糖苷、增稠剂、功能助剂、尿囊素和凝血酸，形成该产品。
8.根据权利要求7所述的一种祛痘、去痘印、去闭合性粉刺的面霜的制备方法，其特征在于，所述S1中化学混合锅使用前需进行清洁消毒。
9.根据权利要求7所述的一种祛痘、去痘印、去闭合性粉刺的面霜的制备方法，其特征在于，所述S1和S2中均匀需要玻璃棒进行混合搅拌。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910767307.7A CN112386554A (zh) | 2019-08-19 | 2019-08-19 | 一种祛痘、去痘印、去闭合性粉刺的面霜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910767307.7A CN112386554A (zh) | 2019-08-19 | 2019-08-19 | 一种祛痘、去痘印、去闭合性粉刺的面霜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112386554A true CN112386554A (zh) | 2021-02-23 |
Family
ID=74603635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910767307.7A Pending CN112386554A (zh) | 2019-08-19 | 2019-08-19 | 一种祛痘、去痘印、去闭合性粉刺的面霜 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112386554A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109125242A (zh) * | 2018-10-30 | 2019-01-04 | 广东康之辰药物研发有限公司 | 一种修复痘印的外用剂及其制备方法 |
-
2019
- 2019-08-19 CN CN201910767307.7A patent/CN112386554A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109125242A (zh) * | 2018-10-30 | 2019-01-04 | 广东康之辰药物研发有限公司 | 一种修复痘印的外用剂及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 彭冠杰等主编: "《美白化妆品科学与技术》", 西安交通大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002216473A1 (en) | A skin cream composition | |
| CN103271833A (zh) | 一种同时具祛痘美白及痘印消除功能的组合物 | |
| CN107811926A (zh) | 一种控油祛痘凝胶 | |
| CN114028295A (zh) | 一种抑菌止痒褪红祛痘修护组合物及其制备方法和应用 | |
| CN112516034A (zh) | 一种植物祛痘剂及其制备方法和用途 | |
| CN102178630A (zh) | 生物酸的化妆品应用方法及生物酸化妆品制剂 | |
| TW201416071A (zh) | 具抗菌、調節皮脂分泌及去角質功效之組成物以去除或防治粉刺 | |
| CN114848517A (zh) | 一种保湿控油消炎抑菌祛痘组合物和包含该组合物的祛痘化妆品及其制备方法 | |
| CN113456570A (zh) | 一种祛痘组合物、祛痘啫喱及其制备方法 | |
| CN104688638A (zh) | 一种夜间补水美白的红石榴牛奶免洗睡眠面膜 | |
| CN112386554A (zh) | 一种祛痘、去痘印、去闭合性粉刺的面霜 | |
| CN115429738B (zh) | 一种祛痘修护焕活精华液及其制备方法 | |
| CN110638692A (zh) | 一种具有抑制青春痘作用的面膜液及其制备方法 | |
| CN111228353A (zh) | 一种用于面部祛痘的抑菌制剂及其制备方法 | |
| KR100643822B1 (ko) | 지모 추출물을 함유하는 조성물 | |
| KR19990039050A (ko) | 말벌 독 추출물을 함유하는 여드름 예방 및 치료제 | |
| KR101859325B1 (ko) | 수소 비누 | |
| CN112409198A (zh) | 一种甜菜碱水杨酸盐及其制备方法 | |
| CN115554213B (zh) | 一种纳米粒径脂质包裹精氨酸的防脱发洗发水及其制备方法 | |
| CN112891294B (zh) | 祛痘消痕修复护肤组合物及含有该组合物的祛痘霜及乳液 | |
| CN115517982A (zh) | 一种白芨祛痘修护凝胶及其制备方法 | |
| JP7044354B2 (ja) | 美白化粧料組成物 | |
| KR20020081582A (ko) | 모발처리제 | |
| CN110897921B (zh) | 一种含再生医学材料的祛痘护肤品及其制备方法 | |
| CN115844792A (zh) | 一种天然来源的祛痘微乳液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210223 |
|
| RJ01 | Rejection of invention patent application after publication |